Physiologic Response to Gender-Affirming Hormones Among Transgender Youth - PubMed (original) (raw)

Physiologic Response to Gender-Affirming Hormones Among Transgender Youth

Johanna Olson-Kennedy et al. J Adolesc Health. 2018 Apr.

Abstract

Purpose: The purpose of this study was to examine the physiologic impact of hormones on youth with gender dysphoria. These data represent follow-up data in youth ages 12-23 years over a two-year time period of hormone administration.

Methods: This prospective, longitudinal study initially enrolled 101 youth with gender dysphoria at baseline from those presenting consecutively for care between February 2011 and June 2013. Physiologic data at baseline and follow-up were abstracted from medical charts. Data were analyzed by descriptive statistics.

Results: Of the initial 101 participants, 59 youth had follow-up physiologic data collected between 21 and 31 months after initiation of hormones available for analysis. Metabolic parameters changes were not clinically significant, with the exception of sex steroid levels, intended to be the target of intervention.

Conclusions: Although the impact of hormones on some historically concerning physiologic parameters, including lipids, potassium, hemoglobin, and prolactin, were statistically significant, clinical significance was not observed. Hormone levels physiologically concordant with gender of identity were achieved with feminizing and masculinizing medication regimens. Extensive and frequent laboratory examination in transgender adolescents may be unnecessary. The use of hormones in transgender youth appears to be safe over a treatment course of approximately two years.

Keywords: Cross-sex hormones; Gender dysphoria; Gender transition; Transgender; Transgender youth.

Copyright © 2017 The Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Comment in

• Collaboration Is Key to Developing Effective Hormonal Treatment Paradigms for Transgender Youth.
  Corathers SD. Corathers SD. J Adolesc Health. 2018 Apr;62(4):361-362. doi: 10.1016/j.jadohealth.2018.01.003. J Adolesc Health. 2018. PMID: 29571433 No abstract available.

Similar articles

• Baseline Physiologic and Psychosocial Characteristics of Transgender Youth Seeking Care for Gender Dysphoria.
  Olson J, Schrager SM, Belzer M, Simons LK, Clark LF. Olson J, et al. J Adolesc Health. 2015 Oct;57(4):374-80. doi: 10.1016/j.jadohealth.2015.04.027. Epub 2015 Jul 21. J Adolesc Health. 2015. PMID: 26208863 Free PMC article.
• Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.
  Defreyne J, Elaut E, Kreukels B, Fisher AD, Castellini G, Staphorsius A, Den Heijer M, Heylens G, T'Sjoen G. Defreyne J, et al. J Sex Med. 2020 Apr;17(4):812-825. doi: 10.1016/j.jsxm.2019.12.020. Epub 2020 Jan 31. J Sex Med. 2020. PMID: 32008926
• Impact of Early Medical Treatment for Transgender Youth: Protocol for the Longitudinal, Observational Trans Youth Care Study.
  Olson-Kennedy J, Chan YM, Garofalo R, Spack N, Chen D, Clark L, Ehrensaft D, Hidalgo M, Tishelman A, Rosenthal S. Olson-Kennedy J, et al. JMIR Res Protoc. 2019 Jul 9;8(7):e14434. doi: 10.2196/14434. JMIR Res Protoc. 2019. PMID: 31290407 Free PMC article.
• MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
  Glintborg D, T'Sjoen G, Ravn P, Andersen MS. Glintborg D, et al. Eur J Endocrinol. 2021 Jun 28;185(2):R49-R63. doi: 10.1530/EJE-21-0059. Eur J Endocrinol. 2021. PMID: 34081614 Review.
• Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
  Nguyen HB, Chavez AM, Lipner E, Hantsoo L, Kornfield SL, Davies RD, Epperson CN. Nguyen HB, et al. Curr Psychiatry Rep. 2018 Oct 11;20(12):110. doi: 10.1007/s11920-018-0973-0. Curr Psychiatry Rep. 2018. PMID: 30306351 Free PMC article. Review.

Cited by

• Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association.
  Streed CG Jr, Beach LB, Caceres BA, Dowshen NL, Moreau KL, Mukherjee M, Poteat T, Radix A, Reisner SL, Singh V; American Heart Association Council on Peripheral Vascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; and Stroke Council. Streed CG Jr, et al. Circulation. 2021 Aug 10;144(6):e136-e148. doi: 10.1161/CIR.0000000000001003. Epub 2021 Jul 8. Circulation. 2021. PMID: 34235936 Free PMC article. Review.
• Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults.
  Iwamoto SJ, Defreyne J, Kaoutzanis C, Davies RD, Moreau KL, Rothman MS. Iwamoto SJ, et al. Ther Adv Endocrinol Metab. 2023 Apr 19;14:20420188231166494. doi: 10.1177/20420188231166494. eCollection 2023. Ther Adv Endocrinol Metab. 2023. PMID: 37113210 Free PMC article. Review.
• Challenges in the care of transgender and gender-diverse youth: an endocrinologist's view.
  Rosenthal SM. Rosenthal SM. Nat Rev Endocrinol. 2021 Oct;17(10):581-591. doi: 10.1038/s41574-021-00535-9. Epub 2021 Aug 10. Nat Rev Endocrinol. 2021. PMID: 34376826 Review.
• Supporting Gender-Related Medical Decision Making for Transgender and Gender-Diverse Individuals: A Scoping Review.
  Lambert A, Pratt A, Conard LAE, Grigg Dean E, Page E, Vaughn LM, Lipstein EA. Lambert A, et al. Transgend Health. 2023 Mar 31;8(2):113-123. doi: 10.1089/trgh.2021.0030. eCollection 2023 Apr. Transgend Health. 2023. PMID: 37013094 Free PMC article.
• Health considerations for transgender women and remaining unknowns: a narrative review.
  Iwamoto SJ, Defreyne J, Rothman MS, Van Schuylenbergh J, Van de Bruaene L, Motmans J, T'Sjoen G. Iwamoto SJ, et al. Ther Adv Endocrinol Metab. 2019 Aug 30;10:2042018819871166. doi: 10.1177/2042018819871166. eCollection 2019. Ther Adv Endocrinol Metab. 2019. PMID: 31516689 Free PMC article. Review.

References

1. 1. Spack NP, Edwards-Leeper L, Feldman HA, et al. Children and adolescents with gender identity disorder referred to a pediatric medical center. Pediatrics 2012;129. - PubMed
2. 1. Khatchadourian K, Amed S, Metzger DL. Clinical management of youth with gender dysphoria in Vancouver.J Pediatr 2014;164:906–11. - PubMed
3. 1. Olson J, Schrager SM, Belzer M, et al. Baseline physiologic and psychosocial characteristics of transgender youth seeking care for gender dysphoria. J Adolesc Health 2015;57:374–80. - PMC - PubMed
4. 1. Smith YL, Van Goozen SH, Kuiper AJ, Cohen-Kettenis PT. Sex reassignment: Outcomes and predictors of treatment for adolescent and adult transsexuals. Psychol Med 2005;35:89–99. - PubMed
5. 1. Delemarre-van de Waal HA, Cohen-Kettenis PT. Clinical management of gender identity disorder in adolescents: A protocol on psychological and paediatric endocrinology aspects. Eur J Endocrinol 2006;155(Suppl. 1):S131–7.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information